Diseases are a product of complex interactions among biological layers that we barely understand. Our platform integrates computational drug prediction with on-demand animal models and cutting-edge screening hardware to rapidly connect behavioral and cognitive symptoms to novel therapeutic targets and treatments in a matter of weeks. Unlike other discovery stage companies, Unravel enables unbiased identification of drug targets that span organ systems, including restoring metabolism and reducing inflammation. 



Join TechBio Companies Driving Patient Impact